Overview

Accuracy of an Echo-Stress Protocol Using Regadenoson With Speckle Tracking

Status:
Active, not recruiting
Trial end date:
2023-08-01
Target enrollment:
Participant gender:
Summary
The goal of this clinical research study is to compare regadenoson nuclear stress testing with echocardiography strain measurements (an ultrasound imaging method that measures hearts function) in detecting coronary artery disease.
Phase:
Phase 4
Details
Lead Sponsor:
M.D. Anderson Cancer Center
Collaborator:
Astellas Scientific & Medical Affairs, Inc.
Treatments:
Regadenoson